Dublin, June 28, 2017 -- Research and Markets has announced the addition of the "Global Neurosurgical Products Market: Drivers, Opportunities, Trends, and Forecasts: 2017-2023" report to their offering.
The Global Neurosurgical Devices Market is estimated to witness a CAGR of 10.5% during the forecast period 2017-2023.
The regions covered in the report are the Americas, EMEA, and Asia Pacific (APAC). The Americas is set to be the leading region for the neurosurgical devices market growth followed by EMEA. There has been a significant increase in the number of individuals undergoing treatment for various neurosurgical procedures in the US. For instance, according to the American Academy of Neurology, neurological disorders accounted for 7% of all global diseases in 2014.
Europe accounted for the second largest market with chronic pain being one of the major complications with rising burden of cerebral disorders cases. In 2015, the public spending on healthcare in Europe amounted to 18% of the overall government expenditure. The expenditure on chronic pain care with neurostimulation devices is directly reimbursed to hospitals within the NHS. Clinical evidence of neurosurgical devices, when compared to other treatment such as drug therapy, is expected to increase during the forecast period.
The APAC neurosurgical devices market revenue is expected to reach $2.4 billion by 2023, growing at a CAGR of 13% during the forecast period 2016-2023. The factors such as high prevalence of neurological diseases, presence of a large pool of patients, increase in disposable income, and rise in awareness about treatment for complex neurosurgeries are owing to a substantial growth in the market. Also, the increase in government spending in healthcare, infrastructure, research centers, and the establishment of manufacturing facilities by major vendors are influencing high growth in the market.
Key Players: Boston Scientific Corp., DePuy Synthes, Inc., Integra LifeSciences Holdings Corp., Medtronic PLC, Stryker Corp., and other predominate & niche players.
Key Topics Covered:
1. Report Outline
2. Executive Summary
3. Market Positioning
3.1 Total Addressable Market (TAM): Neurosurgical Industry
3.2 Segmented Addressable Market (SAM)
3.3 Related Markets
4. Market Outlook
5. Market Characteristics
5.1 Ecosystem
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.2 Restraints
5.3.3 Opportunities
5.3.4 DRO - Impact Analysis
6. Neurosurgical Market by Application: Market Size and Analysis
6.1 Overview
6.2 Neurostimulation devices
6.3 Interventional neurology device
6.4 Cerebrospinal fluid devices
6.5 Neurosurgery devices
6.6 Neurosurgical navigation systems
7. Neurosurgical Market by Regions: Market Size and Analysis
8. Vendor Profiles
8.1 Boston Scientific Corp.
8.2 DePuy Synthes Inc. (a subsidiary of Johnson & Johnson)
8.3 Medtronic PLC
8.4 Stryker Corp.
8.5 Integra LifeSciences Corp.
9. Companies to Watch For
9.1 MicroVention Inc.
9.2 Penumbra Inc.
9.3 Cyberonics Inc
10. Competitive Landscape
10.1 Competitor Product & Geography Benchmarking
10.2 Market Landscape
11 What Our Peers Are Estimating
For more information about this report visit https://www.researchandmarkets.com/research/wk8dks/global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Neurology Devices , Surgical Devices


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Anta Sports Expands Global Footprint With Strategic Puma Stake
Samsung Electronics Shares Jump on HBM4 Mass Production Report 



